Differential susceptibility to motor impulsivity among functional subtypes of Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 12, 2012, Pages 1149-1154

  Wylie, Scott A ^a   Van Wildenberg, Wery Den ^b   Ridderinkhof, K Richard ^b   Claassen, Daniel O ^a   Wooten, George F ^c   Manning, Carol A ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;

AGED; ARTICLE; BODY EQUILIBRIUM; CLINICAL ARTICLE; DECISION MAKING; ERROR; FALL RISK ASSESSMENT; FEMALE; GAIT DISORDER; HUMAN; MALE; MOTOR CONTROL; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RESPONSE TIME; TASK PERFORMANCE; TREMOR;

EID: 84869239812     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303056     Document Type: Article

References (31)

1. Ahlskog JE. Think before you leap: donepezil reduces falls? Neurology 2010;75:1226-7.
2. Blaszcyk JW, Orawlec R, Duda-Klodowska D, et al. Assessment of postural instability in patients with Parkinson's disease. Exp Brain Res 2007;183:107-14. (Pubitemid 47460462)
3. Kerr GK, Worringham CJ, Cole MH, et al. Predictors of future falls in Parkinson disease. Neurology 2010;75:116-24.
4. Wylie SA, Ridderinkhof KR, Bashore TR, et al. The effect of Parkinson's disease on the dynamics of on-line and proactive control during action selection. J Cogn Neurosci 2010;22:2058-73.
5. Simon JR. The effect of an irrelevant directional cue on human information processing. In: Proctor RW, Reeve TG, eds. Stimulus-Response Compatibility: An Integrated Perspective. Amsterdam: North-Holland, 1990:31-88.
6. Ridderinkhof KR. Activation and suppression in conflict tasks: empirical clarification through distributional analyses. In: Prinz W, Hommel B, eds. Common Mechanisms in Perception and Action, Attention & Performance. Oxford: Oxford University Press, 2002:495-519.
7. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-34. (Pubitemid 20351344)
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.
9. Lu CH, Proctor RW. The influence of irrelevant location information on performance: a review of the Simon and spatial Stroop effects. Psychol B Rev 1995;2:174-207.
10. van den Wildenberg WPM, Wylie SA, Forstmann BU, et al. To head or to heed? Beyond the surface of selective action inhibition: a review. Front Hum Neurosci 2010;4:1-13.
11. Kornblum S, Hasbroucq T, Osman A. Dimensional overlap: cognitive basis for stimulus-response compatibility - a model and taxonomy. Psychol Rev 1990;97:253-70.
12. Amboni M, Cozzolino A, Longo K, et al. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 2007;23:395-400.
13. Naismith SL, Shine JM, Lewis SJG. The specific contributions of set-shifting to freezing of gait in Parkinson's disease. Mov Disord 2010;25:1000-4.
14. Plotnik M, Giladi N, Dagan Y, et al. Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state. Exp Brain Res 2011;210:529-38.
15. Vandenbossche J, Deroost N, Soetens E, et al. Freezing of gait in Parkinson disease is associated with impaired conflict resolution. Neurorehabil Neural Repair 2011;25:765-73.
16. Schillaci O, Chiaravalloti A, Pierantozzi M, et al. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT. Int J Mol Med 2011;28:881-6.
17. Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-30. (Pubitemid 44336596)
18. Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-9. (Pubitemid 43844579)
19. Lyros E, Messinis L, Papathanasopoulos P. Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia? Eur J Neurol 2008;15:262-7. (Pubitemid 351257921)
20. Oh JY, Kim YS, Choi BH, et al. Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD). Arch Gerontol Geriatr 2009;49:351-4.
21. Forstmann BU, van den Wildenberg WPM, Ridderinkhof KR. Neural mechanisms, temporal dyanmics, and individual differences in interference control. J Cogn Neurosci 2008;20:1854-65.
22. Nambu A, Tokuno H, Takada M. Functional significance of the cortico-subthalmopallidal 'hyperdirect' pathway. Neurosci Res 2002;43:111-17. (Pubitemid 34627041)
23. Nachev P, Wydell H, O'Neill K, et al. The role of the pre-supplementary motor area in the control of action. Neuroimage 2007;36:155-63.
24. Ridderinkhof KR, Forstmann BU, Wylie SA, et al. Neurocognitive mechanisms of action control: resisting the call of the Sirens. Wiley Interdiscip Rev Cogn Sci 2011;2:174-92.
25. Frank MJ. Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making. Neural Netw 2006;8:1120-36. (Pubitemid 44466333)
26. Wylie SA, Ridderinkhof KR, Elias WJ, et al. Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain 2010;133:3611-24.
27. Eagle DM, Baunez C. Is there an inhibitory-response-control-system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 2010;34:50-72.
28. Evenden JL. Varieties of impulsivity. Psychopharmacology 1999;146:348-61. (Pubitemid 29513276)
29. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psyciatry 2007;78:1182-7. (Pubitemid 350057278)
30. Wylie SA, Claassen DO, Huizenga HM, et al. Dopamine agonists and the suppression of impulsive motor actions in Parkinson's disease. J Cogn Neurosci 2012;24:1709-24.
31. Chung KA, Lobb BM, Nutt JG, et al. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson's disease. Neurology 2010;75:1263-9.